⌘K

/Equities/XLON/RTW

RTW Biotech Opportunities Ltd

/Equities/XLON/RTW

RTW Biotech Opportunities Ltd

/Equities/XLON/RTW

/Equities/XLON/RTW

RTW Biotech Opportunities Ltd

Loading price data...

--

Price Chart

Open: 2.15
High: 2.15
Low: 2.12
Close: 2.12
Change: -0.04 (-1.86%)
Volume: 50,582

Recent RNS announcements

1 May 2026	07:00:02	Total Voting Rights
30 Apr 2026	07:00:03	Transaction in Own Shares
29 Apr 2026	07:00:04	Transaction in Own Shares
28 Apr 2026	07:00:02	Transaction in Own Shares

Annual Reports

24 Apr 2026	Annual Report and Audited Consolidated Financial Statements
17 Apr 2025	Annual Report and Audited Consolidated Financial Statements
25 Apr 2024	Annual Report and Accounts

Directors (2)

RW

Roderick WongMD Managing Partner, Chief Investment Officer

–

Stephanie A. SirotaDirector

–

In the Press

	1 Apr 2026	Morning briefing: Biogen snaps up Apellis in boost BIOG and RTW; Baillie Gifford China Growth bounces back with 34% annual return; BIPS looks for bargains after March madness; JAM manager move; BH Macro disappointment; plus VIP	QuotedData
	30 Mar 2026	RTW Biotech says prospects are compelling as drug developers begin “a new phase of maturity”	QuotedData

Company details

Industry: Financials
Sector: Financial Services
LEI: 549300Q7EXQQH6KF7Z84
Region: Europe
Admission date: 30 Oct 2019
Website: www.rtwfunds.com
X: @RtwLp

Shares details

Shares in issue: 345,967,440
Total Voting Rights: 323,647,437
Treasury Shares: 22,320,003

Last updated: 1 May 2026

Loading price data...

--

Price Chart

Open: 2.15
High: 2.15
Low: 2.12
Close: 2.12
Change: -0.04 (-1.86%)
Volume: 50,582

Recent RNS announcements

1 May 2026	07:00:02	Total Voting Rights
30 Apr 2026	07:00:03	Transaction in Own Shares
29 Apr 2026	07:00:04	Transaction in Own Shares
28 Apr 2026	07:00:02	Transaction in Own Shares

Annual Reports

24 Apr 2026	Annual Report and Audited Consolidated Financial Statements
17 Apr 2025	Annual Report and Audited Consolidated Financial Statements
25 Apr 2024	Annual Report and Accounts

Directors (2)

RW

Roderick WongMD Managing Partner, Chief Investment Officer

–

Stephanie A. SirotaDirector

–

In the Press

	1 Apr 2026	Morning briefing: Biogen snaps up Apellis in boost BIOG and RTW; Baillie Gifford China Growth bounces back with 34% annual return; BIPS looks for bargains after March madness; JAM manager move; BH Macro disappointment; plus VIP	QuotedData
	30 Mar 2026	RTW Biotech says prospects are compelling as drug developers begin “a new phase of maturity”	QuotedData

Company details

Industry: Financials
Sector: Financial Services
LEI: 549300Q7EXQQH6KF7Z84
Region: Europe
Admission date: 30 Oct 2019
Website: www.rtwfunds.com
X: @RtwLp

Shares details

Shares in issue: 345,967,440
Total Voting Rights: 323,647,437
Treasury Shares: 22,320,003

Last updated: 1 May 2026

Parliament Interests

Baroness Blackwood of North Oxford has interests in this issuer

Recent Buybacks

01/04/2026

100,000£201,000

30/03/2026

100,000£190,000

27/03/2026

100,000£194,000

26/03/2026

100,000£196,000

19/03/2026

100,000£189,000

Instrument details

ISIN: GG00BKTRRM22
Exchange: XLON
Market: Main Market
Market Segment: STMM
Market Sector: F25S
Security Description: Ordinary Shares of No Par Value; fully paid
Listing Category: Closed-ended investment funds

Parliament Interests

Baroness Blackwood of North Oxford has interests in this issuer

Recent Buybacks

01/04/2026

100,000£201,000

30/03/2026

100,000£190,000

27/03/2026

100,000£194,000

26/03/2026

100,000£196,000

19/03/2026

100,000£189,000

Instrument details

ISIN: GG00BKTRRM22
Exchange: XLON
Market: Main Market
Market Segment: STMM
Market Sector: F25S
Security Description: Ordinary Shares of No Par Value; fully paid
Listing Category: Closed-ended investment funds

Share Price2.12

Day Change-0.04(-1.86%)

Market Cap$733.5m

1 May 15:24

Market closed

Share Price2.12

Day Change-0.04(-1.86%)

Market Cap$733.5m

1 May 15:24

Market closed